The rare cancer Network: Achievements from 1993 to 2012

Ajaykumar Patel, Mahmut Ozsahin, Rene Olivier Mirimanoff, Sumita Bhatia, Kenneth Chang, Robert Clell Miller

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The Rare Cancer Network (RCN), founded in 1993, performs research involving rare tumors that are not common enough to be the focus of prospective study. Over 55 studies have either been completed or are in progress. The aim of the paper is to present an overview of the 30 studies done through the RCN to date, organized by disease site. Five studies focus on breast pathology, including sarcoma, lymphoma, phyllodes tumor, adenoid cystic carcinoma, and ductal carcinoma in situ in young women. Three studies on prostate cancer address prostatic small cell carcinoma and adenocarcinoma of young and elderly patients. Six studies on head and neck cancers include orbital and intraocular lymphoma, mucosal melanoma, pediatric nasopharyngeal carcinoma, olfactory neuroblastoma, and mucosa-associated lymphoid tissue lymphoma of the salivary glands. There were 4 central nervous system studies on patients with cerebellar glioblastoma multiforme, atypical and malignant meningioma, spinal epidural lymphoma and myxopapillary ependymoma. Outside of these disease sites, there is a wide variety of other studies on tumors ranging from uterine leiomyosarcoma to giant cell tumors of the bone. The studies done by the RCN represent a wide range of rare pathologies that were previously only studied in small series or case reports. With further growth of the RCN and collaboration between members our ability to analyze rare tumors will increase and result in better understanding of their behavior and ultimately help direct research that may improve patient outcomes.

Original languageEnglish (US)
Pages (from-to)110-114
Number of pages5
JournalRare Tumors
Volume4
Issue number3
DOIs
StatePublished - 2012

Fingerprint

Neoplasms
Lymphoma
Intraocular Lymphoma
Olfactory Esthesioneuroblastoma
Phyllodes Tumor
Giant Cell Tumor of Bone
Pathology
Ependymoma
Olfactory Mucosa
Adenoid Cystic Carcinoma
Marginal Zone B-Cell Lymphoma
Aptitude
Carcinoma, Intraductal, Noninfiltrating
Small Cell Carcinoma
Leiomyosarcoma
Meningioma
Glioblastoma
Head and Neck Neoplasms
Salivary Glands
Research

Keywords

  • Oncology
  • Radiotherapy
  • Rare
  • Tumors

ASJC Scopus subject areas

  • Oncology
  • Histology

Cite this

Patel, A., Ozsahin, M., Mirimanoff, R. O., Bhatia, S., Chang, K., & Miller, R. C. (2012). The rare cancer Network: Achievements from 1993 to 2012. Rare Tumors, 4(3), 110-114. https://doi.org/10.4081/rt.2012.e35

The rare cancer Network : Achievements from 1993 to 2012. / Patel, Ajaykumar; Ozsahin, Mahmut; Mirimanoff, Rene Olivier; Bhatia, Sumita; Chang, Kenneth; Miller, Robert Clell.

In: Rare Tumors, Vol. 4, No. 3, 2012, p. 110-114.

Research output: Contribution to journalArticle

Patel, A, Ozsahin, M, Mirimanoff, RO, Bhatia, S, Chang, K & Miller, RC 2012, 'The rare cancer Network: Achievements from 1993 to 2012', Rare Tumors, vol. 4, no. 3, pp. 110-114. https://doi.org/10.4081/rt.2012.e35
Patel A, Ozsahin M, Mirimanoff RO, Bhatia S, Chang K, Miller RC. The rare cancer Network: Achievements from 1993 to 2012. Rare Tumors. 2012;4(3):110-114. https://doi.org/10.4081/rt.2012.e35
Patel, Ajaykumar ; Ozsahin, Mahmut ; Mirimanoff, Rene Olivier ; Bhatia, Sumita ; Chang, Kenneth ; Miller, Robert Clell. / The rare cancer Network : Achievements from 1993 to 2012. In: Rare Tumors. 2012 ; Vol. 4, No. 3. pp. 110-114.
@article{184242221223403d9a3b06d3f0d12022,
title = "The rare cancer Network: Achievements from 1993 to 2012",
abstract = "The Rare Cancer Network (RCN), founded in 1993, performs research involving rare tumors that are not common enough to be the focus of prospective study. Over 55 studies have either been completed or are in progress. The aim of the paper is to present an overview of the 30 studies done through the RCN to date, organized by disease site. Five studies focus on breast pathology, including sarcoma, lymphoma, phyllodes tumor, adenoid cystic carcinoma, and ductal carcinoma in situ in young women. Three studies on prostate cancer address prostatic small cell carcinoma and adenocarcinoma of young and elderly patients. Six studies on head and neck cancers include orbital and intraocular lymphoma, mucosal melanoma, pediatric nasopharyngeal carcinoma, olfactory neuroblastoma, and mucosa-associated lymphoid tissue lymphoma of the salivary glands. There were 4 central nervous system studies on patients with cerebellar glioblastoma multiforme, atypical and malignant meningioma, spinal epidural lymphoma and myxopapillary ependymoma. Outside of these disease sites, there is a wide variety of other studies on tumors ranging from uterine leiomyosarcoma to giant cell tumors of the bone. The studies done by the RCN represent a wide range of rare pathologies that were previously only studied in small series or case reports. With further growth of the RCN and collaboration between members our ability to analyze rare tumors will increase and result in better understanding of their behavior and ultimately help direct research that may improve patient outcomes.",
keywords = "Oncology, Radiotherapy, Rare, Tumors",
author = "Ajaykumar Patel and Mahmut Ozsahin and Mirimanoff, {Rene Olivier} and Sumita Bhatia and Kenneth Chang and Miller, {Robert Clell}",
year = "2012",
doi = "10.4081/rt.2012.e35",
language = "English (US)",
volume = "4",
pages = "110--114",
journal = "Rare Tumors",
issn = "2036-3605",
publisher = "PagePress",
number = "3",

}

TY - JOUR

T1 - The rare cancer Network

T2 - Achievements from 1993 to 2012

AU - Patel, Ajaykumar

AU - Ozsahin, Mahmut

AU - Mirimanoff, Rene Olivier

AU - Bhatia, Sumita

AU - Chang, Kenneth

AU - Miller, Robert Clell

PY - 2012

Y1 - 2012

N2 - The Rare Cancer Network (RCN), founded in 1993, performs research involving rare tumors that are not common enough to be the focus of prospective study. Over 55 studies have either been completed or are in progress. The aim of the paper is to present an overview of the 30 studies done through the RCN to date, organized by disease site. Five studies focus on breast pathology, including sarcoma, lymphoma, phyllodes tumor, adenoid cystic carcinoma, and ductal carcinoma in situ in young women. Three studies on prostate cancer address prostatic small cell carcinoma and adenocarcinoma of young and elderly patients. Six studies on head and neck cancers include orbital and intraocular lymphoma, mucosal melanoma, pediatric nasopharyngeal carcinoma, olfactory neuroblastoma, and mucosa-associated lymphoid tissue lymphoma of the salivary glands. There were 4 central nervous system studies on patients with cerebellar glioblastoma multiforme, atypical and malignant meningioma, spinal epidural lymphoma and myxopapillary ependymoma. Outside of these disease sites, there is a wide variety of other studies on tumors ranging from uterine leiomyosarcoma to giant cell tumors of the bone. The studies done by the RCN represent a wide range of rare pathologies that were previously only studied in small series or case reports. With further growth of the RCN and collaboration between members our ability to analyze rare tumors will increase and result in better understanding of their behavior and ultimately help direct research that may improve patient outcomes.

AB - The Rare Cancer Network (RCN), founded in 1993, performs research involving rare tumors that are not common enough to be the focus of prospective study. Over 55 studies have either been completed or are in progress. The aim of the paper is to present an overview of the 30 studies done through the RCN to date, organized by disease site. Five studies focus on breast pathology, including sarcoma, lymphoma, phyllodes tumor, adenoid cystic carcinoma, and ductal carcinoma in situ in young women. Three studies on prostate cancer address prostatic small cell carcinoma and adenocarcinoma of young and elderly patients. Six studies on head and neck cancers include orbital and intraocular lymphoma, mucosal melanoma, pediatric nasopharyngeal carcinoma, olfactory neuroblastoma, and mucosa-associated lymphoid tissue lymphoma of the salivary glands. There were 4 central nervous system studies on patients with cerebellar glioblastoma multiforme, atypical and malignant meningioma, spinal epidural lymphoma and myxopapillary ependymoma. Outside of these disease sites, there is a wide variety of other studies on tumors ranging from uterine leiomyosarcoma to giant cell tumors of the bone. The studies done by the RCN represent a wide range of rare pathologies that were previously only studied in small series or case reports. With further growth of the RCN and collaboration between members our ability to analyze rare tumors will increase and result in better understanding of their behavior and ultimately help direct research that may improve patient outcomes.

KW - Oncology

KW - Radiotherapy

KW - Rare

KW - Tumors

UR - http://www.scopus.com/inward/record.url?scp=84867908533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867908533&partnerID=8YFLogxK

U2 - 10.4081/rt.2012.e35

DO - 10.4081/rt.2012.e35

M3 - Article

C2 - 23087791

AN - SCOPUS:84867908533

VL - 4

SP - 110

EP - 114

JO - Rare Tumors

JF - Rare Tumors

SN - 2036-3605

IS - 3

ER -